{"id":"https://openalex.org/W2053438801","doi":"https://doi.org/10.1111/j.1360-0443.2009.02646.x","title":"Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment","display_name":"Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment","alternate_titles":[],"publication_year":2009,"publication_date":"2009-08-03","ids":{"openalex":"https://openalex.org/W2053438801","doi":"https://doi.org/10.1111/j.1360-0443.2009.02646.x","mag":"2053438801","pmid":"https://pubmed.ncbi.nlm.nih.gov/19686530"},"language":"en","primary_location":{"id":"doi:10.1111/j.1360-0443.2009.02646.x","doi":"https://doi.org/10.1111/j.1360-0443.2009.02646.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.2009.02646.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2053438801"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052035076","display_name":"Peter H\u00e1jek","orcid":"https://orcid.org/0000-0001-9160-4296","observed_orcids":["https://orcid.org/0000-0001-9160-4296"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2802582725","display_name":"Gentofte Hospital","ror":"https://ror.org/051dzw862","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802582725"]}],"countries":["DK","GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter Hajek","raw_affiliation_strings":["Wolfson Institute of Preventive Medicine, UK Centre for Tobacco Control Studies, Barts and The London, Queen Mary University of London, London E1 2AD, UK. p.hajek@qmul.ac.uk","Queen Mary University of London, London, UK, Gentofte University Hospital, Copenhagen, Denmark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wolfson Institute of Preventive Medicine, UK Centre for Tobacco Control Studies, Barts and The London, Queen Mary University of London, London E1 2AD, UK. p.hajek@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079"]},{"raw_affiliation_string":"Queen Mary University of London, London, UK, Gentofte University Hospital, Copenhagen, Denmark,","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2802582725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074256236","display_name":"Philip T\u00f8nnesen","orcid":"https://orcid.org/0000-0002-7351-5115","observed_orcids":["https://orcid.org/0000-0002-7351-5115"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philip T\u00f8nnesen","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059476697","display_name":"Carmen Arteaga","orcid":"https://orcid.org/0000-0003-2424-7123","observed_orcids":["https://orcid.org/0000-0003-2424-7123"]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carmen Arteaga","raw_affiliation_strings":["and University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087610563","display_name":"Cristina Russ","orcid":"https://orcid.org/0000-0001-7248-9712","observed_orcids":["https://orcid.org/0000-0001-7248-9712"]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cristina Russ","raw_affiliation_strings":["and University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051492549","display_name":"Serena Tonstad","orcid":"https://orcid.org/0000-0003-2809-7636","observed_orcids":["https://orcid.org/0000-0003-2809-7636"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Serena Tonstad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5052035076"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2802582725"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":4.967,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.945981,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"104","issue":"9","first_page":"1597","last_page":"1602"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/varenicline","display_name":"varenicline","score":1.0},{"id":"https://openalex.org/keywords/smoking-relapse-prevention","display_name":"smoking relapse prevention","score":0.8980000019073486},{"id":"https://openalex.org/keywords/extended-treatment","display_name":"extended treatment","score":0.5540000200271606},{"id":"https://openalex.org/keywords/smoking-cessation","display_name":"smoking cessation","score":0.5640000104904175},{"id":"https://openalex.org/keywords/continuous-abstinence","display_name":"continuous abstinence","score":0.6809999942779541},{"id":"https://openalex.org/keywords/nicotine-receptor-partial-agonist","display_name":"nicotine receptor partial agonist","score":0.5820000171661377},{"id":"https://openalex.org/keywords/treatment-heterogeneity","display_name":"treatment effect heterogeneity","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C2777053506","wikidata":"https://www.wikidata.org/wiki/Q411330","display_name":"Varenicline","level":3,"score":0.9752558469772339},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.8216743469238281},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.7621109485626221},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7418553829193115},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6704698801040649},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5876080393791199},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.5017921924591064},{"id":"https://openalex.org/C3017583242","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Placebo group","level":4,"score":0.43006226420402527},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.41832396388053894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3520495295524597},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3495097756385803},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33565807342529297},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068580","descriptor_name":"Varenicline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074606","descriptor_name":"Smoking Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012907","descriptor_name":"Smoking","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016540","descriptor_name":"Smoking Cessation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016540","descriptor_name":"Smoking Cessation","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1360-0443.2009.02646.x","doi":"https://doi.org/10.1111/j.1360-0443.2009.02646.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.2009.02646.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"pmid:19686530","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19686530","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction (Abingdon, England)","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/73814fa0-7916-11df-928f-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://curis.ku.dk/portal/da/publications/varenicline-in-prevention-of-relapse-to-smoking-effect-of-quit-pattern-on-response-to-extended-treatment(73814fa0-7916-11df-928f-000ea68e967b).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hajek, P, T\u00f8nnesen, P, Arteaga, C, Russ, C & Tonstad, S 2009, 'Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment', Addiction, vol. 104, no. 9, pp. 1597-602. https://doi.org/10.1111/j.1360-0443.2009.02646.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3315393415","display_name":"The UK Centre for Tobacco Control Studies","funder_award_id":"ES/G007489/1","funder_id":"https://openalex.org/F4320334630","funder_display_name":"Economic and Social Research Council"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320334630","display_name":"Economic and Social Research Council","ror":"https://ror.org/03n0ht308"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1973626983","https://openalex.org/W1978691251","https://openalex.org/W2006207187","https://openalex.org/W2029013190","https://openalex.org/W2053457282","https://openalex.org/W2055930372","https://openalex.org/W2061219090","https://openalex.org/W2087860813","https://openalex.org/W2105637052","https://openalex.org/W2107287800","https://openalex.org/W2118061336","https://openalex.org/W2119214137","https://openalex.org/W2122435775","https://openalex.org/W2126739627","https://openalex.org/W2143238807","https://openalex.org/W2163539177","https://openalex.org/W4211124521","https://openalex.org/W7096198087"],"related_works":["https://openalex.org/W1901029863","https://openalex.org/W2053457282","https://openalex.org/W4308933783","https://openalex.org/W1997547701","https://openalex.org/W2003078192","https://openalex.org/W1549904073","https://openalex.org/W1978199010","https://openalex.org/W1816201445","https://openalex.org/W4401251865","https://openalex.org/W4396577148"],"abstract_inverted_index":{"AIM:":[0],"While":[1],"older":[2],"behavioural":[3],"and":[4,118,131,280],"pharmacological":[5],"approaches":[6],"to":[7,10,36,42,56,84,191,248,285],"preventing":[8],"relapse":[9,275],"smoking":[11,109,257],"show":[12],"little":[13],"efficacy,":[14],"a":[15],"recent":[16],"randomized":[17,83],"trial":[18,32],"of":[19,23,51,66,76,93,133,157,166,229,274],"an":[20,264],"extended":[21,201,288],"course":[22,50,61],"varenicline":[24,81,88,120],"reported":[25],"positive":[26],"results.":[27],"In":[28],"this":[29],"secondary":[30],"analysis,":[31],"data":[33],"were":[34,82,97,246],"examined":[35,112],"see":[37],"whether":[38],"smokers":[39,254],"who":[40,149,173,189,255,262],"manage":[41],"achieve":[43],"abstinence":[44,126,193,270],"only":[45],"later":[46],"in":[47,124,141,171,176,194,267],"the":[48,60,73,94,100,106,113,119,195,227,230],"original":[49],"treatment":[52,79,159,202,234,249,289],"are":[53],"more":[54,199,283],"likely":[55,284],"benefit":[57,286],"from":[58,99,200,207,287],"having":[59],"extended.":[62],"METHODS:":[63],"A":[64],"total":[65],"1208":[67],"patients":[68,204],"abstinent":[69,98,206],"for":[70],"at":[71,128,154,163],"least":[72],"last":[74,152,174],"week":[75,129,155,177,197,208],"12":[77],"weeks'":[78],"with":[80,169,226,233,253,290],"3":[85],"months":[86,278],"continued":[87],"or":[89],"placebo.":[90],"Overall,":[91],"44%":[92],"12-week":[95],"abstainers":[96],"target":[101],"quit":[102,116,161,231,256],"date":[103],"(TQD),":[104],"while":[105],"rest":[107],"stopped":[108],"later.":[110],"We":[111],"relationship":[114],"between":[115],"pattern":[117,232],"versus":[121,217],"placebo":[122],"difference":[123],"continuous":[125],"rates":[127,146,162],"52":[130,164],"contributions":[132],"baseline":[134],"patient":[135,244],"characteristics.":[136],"RESULTS:":[137],"With":[138],"increasing":[139],"delay":[140,266],"initial":[142,265],"quitting,":[143],"12-month":[144],"success":[145],"declined.":[147],"Participants":[148],"had":[150,160],"their":[151,259],"cigarette":[153],"11":[156],"open-label":[158],"weeks":[165],"5.7%":[167],"compared":[168],"54.9%":[170],"those":[172,261],"smoked":[175],"1":[178,209],"[odds":[179],"ratio":[180],"(OR)":[181],"20.3":[182],"(6.3,":[183],"65.9);":[184],"P":[185,214,222],"<":[186],"0.0001].":[187],"Patients":[188],"failed":[190],"initiate":[192],"first":[196],"benefited":[198],"than":[203],"continuously":[205],"[OR":[210],"1.7":[211],"(1.2,":[212],"2.4);":[213],"=":[215,223,240],"0.0015":[216],"OR":[218],"1.1":[219],"(0.8,":[220],"1.5);":[221],"0.6995,":[224],"respectively;":[225],"interaction":[228],"effect":[235],"reaching":[236],"borderline":[237],"significance":[238],"(P":[239],"0.0494)].":[241],"No":[242],"other":[243],"characteristics":[245],"related":[247],"effect.":[250],"CONCLUSIONS:":[251],"Compared":[252],"on":[258],"TQD,":[260],"have":[263,271],"achieving":[268],"sustained":[269],"increased":[272],"risk":[273],"even":[276],"several":[277],"later,":[279],"may":[281],"be":[282],"varenicline.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2053438801","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
